October 28, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the intersection of law, politics, and commerce.
Maine’s pesticide recall exposed Chinese-made fumigants bleeding into licensed cannabis supply chains. New York’s $30 million enforcement debacle showed what happens when regulators can’t manage recalls they order. And Ohio’s legislature just dismantled key protections from the state’s voter-approved cannabis law, replacing equity with enforcement.
Each story points to the same pattern: fragile systems built on political compromise now showing their stress points. From pesticide control to product recalls to democratic will, the cannabis industry’s regulatory foundation is wobbling - and Washington’s watching (even during a shutdown).
Policy, Decoded is powered by THC Group, strategic advisors to the cannabis, hemp, and alcohol industries. If these insights help you see what’s coming, imagine what we could do working directly for you.
🎧 Listen to the latest episode of The Hybrid Podcast featuring Pam Epstein on hemp’s high-stakes crossroads - and stay tuned for our new episode this week with Kristin and Eric Rogers of LEVIA on how they built, sold, and reclaimed their brand.
☣️ Maine’s recall links Chinese pesticides to U.S. cannabis
⚖️ New York’s compliance crisis leaves $30M in limbo
🏛️ Ohio lawmakers roll back what voters legalized
Thanks, as always, for reading. We’re here when you need us.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Maine's Office of Cannabis Policy recalled Yani-branded vape cartridges sold at 21 licensed dispensaries after testing confirmed unsafe levels of chlorfenapyr, a pesticide banned for human consumption that California authorities previously documented at Chinese-operated illicit grows in both states. The recall affects certain live resin cartridges distributed between July 10th and October 16th, triggered by a consumer complaint about adverse reactions including fever, sweating, nausea, and altered mental status. Chlorfenapyr appears in Chinese-labeled fumigant blends that California traced to Maine hoop house operations, with identical mylar bags of toxins found at illicit facilities in both states now surfacing in Maine's regulated supply chain. The pesticide remains available through US grow supply stores and online retailers despite federal prohibition on consumable products, and eight of the thirteen chemicals found in these Chinese fumigant cocktails aren't on Maine's mandatory testing panel, meaning labs may lack protocols to detect contamination from these specific toxins. When the same banned Chinese fumigants contaminate licensed products in California and Maine, you're seeing informal interstate commerce in cultivation inputs that no state regulatory system can intercept, with pesticides moving freely across borders while cannabis itself remains trapped in jurisdiction-specific supply chains.
💡 Why It Matters: Cannabis licensing demands a level of supply chain diligence and operational vigilance nearly unmatched in American agriculture, yet the structural barriers to achieving that standard keep multiplying. The same Chinese-made fumigants contaminating licensed products in California and Maine demonstrate the actual interstate commerce in cultivation inputs that operates completely outside the seed-to-sale tracking infrastructure that regulators have built to contain cannabis movement. There are banned chemicals flowing freely across state borders while the plant material itself remains locked within individual jurisdictions. Federal prohibition prevents EPA from approving pesticides for cannabis cultivation or USDA from researching safe application protocols, leaving licensed operators without approved pest management tools and state regulators playing whack-a-mole with novel chemical combinations as fast as laboratories can identify them. Licensed operators face pricing pressure from untested, untaxed illicit competition while lacking access to the approved pesticide options that every other American crop receives through federal research and registration. Some turn to banned chemicals rather than lose crops to mold and pests that federally supported agriculture resolved decades ago. It is a regulatory violation, sure. But only if you catch it. Maine's testing regime requires pesticide screening but laboratories can only test for known compounds, and each new fumigant cocktail that appears requires protocol updates, staff training, and equipment calibration before detection becomes possible, turning consumer safety into a reactive chase rather than proactive prevention. The contamination, by the way, will hand rescheduling opponents in Congress exactly the ammunition they need, as China hawks already concerned about foreign land acquisition and agricultural supply chain vulnerabilities now have documented evidence of Chinese-sourced toxins entering American consumer products through cannabis supply chains. Pay no attention, of course, to the fact that that federal prohibition prevents agencies like USDA and EPA from regulating or monitoring that same activity…
🧠 THC Group Take: Maine caught this one. Consumer complained, contamination confirmed, recall issued. The system did what it's supposed to do when something slips through initial screening. Now comes the harder part. Maine should add those thirteen chemicals from the Chinese fumigant blends to its mandatory testing panel, support labs in ensuring they can test for it, and trace how banned pesticides got into a licensed facility in the first place. Were procurement controls broken? Did the cultivator know what they were buying? Publishing answers helps every other state, because this vulnerability exists in all markets - medical and adult-use alike. Here's the absurdity regulators are managing: states have built pharmaceutical-grade testing for a Schedule 1 narcotic, so of course federal prohibition bars the agencies that approve pesticides and fund crop research from helping at all. Licensed operators need to control pests without approved tools - and some are cheating. Illicit operators use whatever maximizes yield. State labs play catch-up identifying novel chemical combinations after they've already reached retail shelves. It's reactive by design, which means it's inadequate by definition. Rescheduling doesn't solve this tomorrow - EPA pesticide approvals take years, USDA research programs need sustained appropriations - but it would let federal agriculture agencies start building approval infrastructure that corn and soybean farmers take for granted. The political timing couldn't be worse for rescheduling advocates. China hawks in Congress now have documented evidence of foreign-sourced toxins entering American consumer products through supply chains that federal prohibition prevents agencies from monitoring. That's not a drug policy debate anymore.
Fast-moving headlines, flagged for what matters.
New York's Office of Cannabis Management charged Omnium Health with running a licensing inversion scheme, allegedly renting its processor license to unlicensed operators and flooding the legal market with potentially unregulated vapes and edibles produced for 17 brands. OCM requested a recall of roughly $30 million in product but seven months after the initial investigation began, no official recall has been issued and retailers are stuck holding embargoed inventory from April with no reimbursement protocol. The agency told retailers there are no known public health risks, directly contradicting internal documents that cited violations jeopardizing "immediate health, safety, or well-being of the public" including failed inventory tracking. Dispensary owners report zero guidance on who pays for affected product or what to tell customers, with some operators scrambling to sell questioned inventory before an official recall materializes. When your regulatory agency can identify major compliance violations, embargo product, investigate for months, and still can't execute a basic recall or tell retailers whether inventory is safe, the compliance overhead that licensed operators pay for becomes pure cost without corresponding consumer protection, explaining why New York's legal market keeps losing to illicit operators despite premium pricing justified by safety claims. (GreenState)
Speaking of that recall…Oregon edibles brand Gron is pushing back hard against New York regulators' claim that it participated in Omnium's reverse licensing scheme, with president Draper Bender telling Crain's the company has lawsuits drafted and ready if OCM moves forward with threatened product recalls. Bender insists Gron's arrangement was a white-label intellectual property deal approved by regulators back in March 2024, not the rent-a-license structure OCM now calls illegal, and that the relationship ended in August when Gron took over its own manufacturing. The company maintains it uploaded documentation to OCM's system and received approval notifications, creating what Bender calls a "massive paper trail" that contradicts the agency's current enforcement stance. OCM named Gron alongside STIIIZY and Mfused as brands facing recalls during last week's press conference announcing charges against Omnium, but the agency refuses to comment on pending investigations while Gron's attorney argues regulators are just "sowing confusion in the marketplace." The dispute highlights New York's chaotic enforcement environment where operators claim they followed approved structures only to face retroactive crackdowns, and whether OCM's documentation systems created reasonable reliance that now looks like regulatory entrapment. (Crain's New York Business)
The Tenth Circuit Court of Appeals ruled Monday that Wyoming's 2024 ban on hemp-derived THC products doesn't violate federal law, rejecting arguments from hemp retailers that the Farm Bill preempts stricter state definitions or that the ban unconstitutionally takes their property. The court dismissed claims that Wyoming's law banning products with more than 0.3% delta-9 THC or any delta-8 THC violates interstate commerce protections, finding the retailers failed to show the state burden on commerce outweighs local benefits or that they actually transport products across state lines. Judges ruled the Fifth Amendment's protection against government taking applies to real property not personal property, citing Prohibition-era cases where alcohol vendors lost their businesses and noting that "the pendulum of politics swings periodically between restriction and permission" in vice regulation. The decision also rejected vagueness challenges to Wyoming's ban on "psychoactive" hemp products, holding that dictionary definitions provide sufficient notice even when terms invite conflicting interpretations in different contexts. The Tenth Circuit's ruling establishes that states retain authority to define hemp more restrictively than federal law without triggering preemption, creating a circuit-level precedent that other states can ban Farm Bill-compliant products and courts will defer to state regulatory choices over industries that "benefitted for several years from operating within a legal market" that legislators later closed. (Cowboy State Daily)
Ohio's legislature advanced new legislation eliminating the social equity fund that voters approved as part of the state's cannabis tax distribution scheme, redirecting revenue to only substance abuse programs, host communities, and administrative costs. The compromise bill kept the 36% local tax for communities hosting dispensaries but dropped a proposal to raise the state excise tax from 10% to 15%, while adding restrictions nowhere in the 2023 constitutional amendment that 57% of voters approved. Lawmakers cut home cultivation from 12 plants to six, reduced extract THC limits from 90% to 70%, banned public consumption, and made exceeding home grow limits a felony trafficking offense instead of a minor violation. The bill also requires marijuana transport in original unopened packaging and eliminates legal protections the constitutional amendment provided, though legislators dropped proposals to ban trunk transport requirements and deny unemployment benefits to workers fired for cannabis use. Ohio's legislature joins Florida and South Dakota in using their authority to undermine voter-approved cannabis measures by eliminating equity provisions and adding criminal penalties, establishing a pattern where lawmakers hostile to legalization can't repeal ballot initiatives but can hollow them out through follow-up legislation that contradicts voter intent. (The Center Square)
🏛️ Omaha Tribe Launches Cannabis Commission While Nebraska's Voter-Approved Program Remains Paralyzed
The Omaha Tribe of Nebraska held its first Cannabis Commission meeting Monday to finalize regulations for adult-use and medical cannabis sales on tribal lands, positioning itself to open dispensaries in early 2026 while the state's voter-approved medical program remains mired in delays and legal threats. Nebraska voters approved medical cannabis with 71% support in November 2024, but Governor Jim Pillen's appointed, albeit hamstrung, commission has restricted flower sales, limited patients to 5 grams of THC every 90 days, capped the state at just 12 dispensaries, and missed the October 1st licensing deadline after two commission members resigned at Pillen's request. The tribe legalized both medical and adult-use cannabis in July under its sovereignty, citing federal budget cuts slashing 30% of tribal programs and the need for economic development, with Attorney General John Cartier calling the state's approach "a non-workable industry" designed to fail. Nebraska's Attorney General has threatened to sue the state commission as soon as licenses issue, creating legal uncertainty that deters business investment, while the tribe faces no such constraints under federal recognition of tribal sovereignty. When a state government actively undermines its own voter-approved medical program with restrictions found nowhere in statute while a federally recognized tribe on Nebraska soil prepares to sell adult-use cannabis to anyone 21 and older, you're watching tribal nations fill the regulatory vacuum that hostile state governments create, establishing a sovereignty framework that could reshape cannabis access across Indian Country. (WOWT Omaha)
Georgia lawmakers finished four legislative hearings on cannabis policy caught between parents testifying that restrictive medical cannabis laws force them to buy illegal product or unregulated hemp from gas stations, and medical experts warning about psychosis risks and emergency room visits from children eating hemp edibles. The state's 2014 medical cannabis law limits patients to low-THC oil from six licensed providers, excluding flower and vapes, with conditions so narrowly defined that a cancer patient couldn't qualify because her disease wasn't yet end stage. Meanwhile, the 2018 Farm Bill's hemp loophole has flooded Georgia stores with intoxicating products containing Delta-8, Delta-9, Delta-11, THCP, and unregulated derivatives that poison control reports caused 1,900 pediatric exposure calls since 2022. House Speaker Jon Burns convened the Blue Ribbon committee after the Senate rejected expanding medical THC limits and tried banning hemp beverages while the House pushed for broader access, leaving lawmakers with no research base to guide policy and competing anecdotes about whether cannabis saves lives or destroys brains. Georgia's dysfunction crystallizes the policy trap that conservative states created: medical programs so restrictive they push patients to either break the law or buy untested hemp products engineered by what one official called "dorm room chemists," while legislators debate which option causes more harm. (Northwest Georgia News)
A Franklin County judge extended the restraining order blocking Governor Mike DeWine's emergency ban on intoxicating hemp products through December 2nd, keeping THC drinks and hemp edibles on shelves while three companies challenge the governor's authority to shut down their businesses without legislative action. DeWine announced the emergency order earlier this month targeting products with more than 0.5mg THC per serving or 2mg per package, calling synthetic hemp "simply dangerous" and giving the ban a 90-day lifespan while lawmakers decide whether to extend it. The restraining order issued October 14th was set to expire but the court extended it as oral arguments continue in the lawsuit filed by Fumee Smoke and Vape, Invicta Nutraceuticals, and Titan Logistics Group. Ohio lawmakers are simultaneously working on legislation to create licensed hemp dispensaries that could sell THC products only to adults 21 and older, mirroring the regulatory framework for adult-use cannabis. DeWine's emergency ban strategy borrowed from similar moves in Texas, California, and New York - using executive authority to crack down on hemp while legislation catches up, but Ohio's court is questioning whether governors can unilaterally shut down businesses operating under federal hemp law without going through the legislative process first. (WLWT Cincinnati)
Tennessee regulators granted hemp retailers a six-month extension to sell THCA flower and products until May 2026, backing away from the January 1st deadline after industry pushback and recognizing that immediate enforcement would destroy businesses built around products that were legal when operators made their investments. The extension applies only to businesses holding permits issued before the legislature banned intoxicating hemp in March, creating a two-tier market where legacy operators can keep selling while new entrants remain locked out. Tennessee's THCA ban passed with overwhelming legislative support and Governor Bill Lee's signature, but regulators are discovering that shutting down established businesses overnight creates more political problems than letting them wind down gradually. The extension bought time but solved nothing, as May 2026 still means hundreds of retailers either pivot entirely or close, and the legacy permit structure favors established players while blocking new competition in what's left of the legal hemp market. When states ban products that entire industries built around, the regulatory challenge isn't just enforcement but managing the economic wreckage, and Tennessee's approach of grandfathering existing operators while blocking new ones creates market distortions that typically benefit whoever had the foresight or luck to get licensed before the ban. (Tennessee Healthy Alternatives Association)
Dalitso LLC, operating Beyond Hello Cannabis Dispensary, filed a lawsuit in Virginia circuit court naming DoorDash, Total Wine, and beverage distributors for allegedly selling and delivering hemp drinks exceeding Virginia's 2mg THC limit per package, giving unlicensed operators an unfair advantage over regulated dispensaries. The complaint claims Total Wine's Arlington store sold four-packs of THC soda containing 5.65mg total THC and DoorDash delivered these products across Virginia without the packaging, testing, or age verification requirements that licensed cannabis retailers must follow. The lawsuit seeks $20 million in damages plus treble damages under Virginia's business conspiracy statute, arriving days after a short-seller report alleged DoorDash hired unauthorized workers, compounding legal and investor scrutiny of the delivery platform. The case marks the first time a major delivery app faces formal accusations of facilitating illegal cannabis sales, with the dispensary arguing DoorDash acted "in concert" with retailers to compete against Virginia's regulated medical market without licensing or oversight. When licensed operators sue delivery platforms instead of just the retailers selling over-limit products, they're targeting the infrastructure that makes hemp loophole exploitation scalable, potentially forcing apps like DoorDash, Uber Eats, and Instacart to either verify THC content before delivery or exit the intoxicating hemp market entirely to avoid liability. (The Maine Wire)
A federal judge has stayed the Florida medical marijuana patients' gun rights case while SCOTUS decides U.S. v. Hemani, which directly addresses whether Section 922(g)(3)'s firearm ban on cannabis users violates the Second Amendment. The Trump DOJ requested the pause and cited both the pending Supreme Court decision and government shutdown resource constraints. Chief Judge Allen Winsor granted the unopposed stay, suspending all deadlines until Hemani resolves the constitutionality question that's driving circuit splits nationwide. The Florida case involves two medical cannabis patients denied gun purchases and a former police officer who wants medical access without losing firearm rights. DOJ picked Hemani as the test case for a reason: the defendant sold cocaine, used multiple drugs, and has alleged Iranian ties, giving justices an easier path to uphold the ban compared to sympathetic medical patients in other pending cases. The court's reasoning will either crack open Second Amendment protections for state-legal medical users nationwide or let DOJ keep running with its "habitual user" theory that never actually appears in the statute text. (Marijuana Moment)
Zurich is pushing its regulated cannabis pilot two years past the original 2026 end date after first-year data showed over 90% of the 2,300 participants now buy exclusively from licensed pharmacies instead of illicit sources. The city council approved another 800,000 Swiss francs to consolidate findings and expand enrollment to 3,000 participants, specifically targeting women and occasional users who've been underrepresented in the study population. Switzerland's federal government already greenlit the expansion earlier this year, and Zurich wants more time to measure long-term public health impacts and black market displacement effects. The pilot tests alternatives to prohibition by letting registered participants buy cannabis through pharmacy channels while researchers track consumption patterns and social outcomes. States debating social consumption or limited pilot programs should watch how Switzerland's pharmacy distribution model nearly eliminated black market purchases within twelve months, though that success depends on controlled enrollment that no US jurisdiction could legally replicate without federal changes. (MMJ Daily)
From the hearing room to the comment section — we’re watching it all.
🍁 BC's eight-week public service strike ended Sunday with a tentative deal giving workers 3% annual wage increases over four years, restoring cannabis and liquor distribution after more than 25,000 workers shut down government-run stores and warehouses starting September 2nd. The union initially sought 4% annual raises but settled for 3% plus targeted adjustments for lowest-paid workers after mediation, with restaurants and bars reporting crisis-level impacts from inability to restock alcohol inventory during the strike. The deal exposes how BC's provincial monopoly distribution system creates single points of failure that don't exist in privatized US markets, where private distributors and retailers can't all strike simultaneously and alternative supply chains remain operational. (BC General Employees' Union)
🍷 NIDA-funded research out of Oregon found dispensary access correlates with reduced heavy drinking among adults 21-24 and 65+, supporting the substitution hypothesis that's had alcohol distributors quietly lobbying against cannabis expansion for years. The study tracked 61,000 Oregonians from 2014-2022 and found higher cannabis retail density meant lower odds of heavy alcohol use in those age brackets, though frequent cannabis use also increased with greater retail access across all adult demographics. What's notable isn't the substitution effect - we've seen that pattern in state-level data for years - but that federal drug abuse research dollars are now funding studies treating dispensary proximity as a modifiable community risk factor that "can be regulated through an array of approaches," the public health framing that typically precedes zoning restrictions and density caps. (American Journal of Preventive Medicine)